Mesa Laboratories Inc.
09/08/2026 | Press release | Distributed by Public on 09/08/2026 13:26
Proxy Results (Form 8-K)
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On September 8, 2026, the Company held its annual meeting of shareholders (the "Annual Meeting"). Holders of 5,595,869 shares of Mesa's common stock were entitled to vote, of which 4,872,692 shares were represented in person or by proxy at the Annual Meeting.
The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company's proxy statement for the Annual Meeting, are as follows:
Proposal 1 -Election of directors
Each of John Sullivan, Siddhartha Kadia, Shiraz Ladiwala, Jennifer "Jenny" Alltoft, Mark Capone, Shannon Hall, and R. Tony Tripeny was elected to the Board of Directors of Mesa to hold office for a one-year term, until the 2027 annual meeting of shareholders:
|
|
|
For
|
|
|
Withheld
|
|
|
Broker
Non-Votes
|
|
|||
|
John Sullivan, Ph.D.
|
|
|
4,388,976
|
|
|
|
145,521
|
|
|
|
338,195
|
|
|
Siddhartha Kadia, Ph.D.
|
|
|
4,421,045
|
|
|
|
113,452
|
|
|
|
338,195
|
|
|
Shiraz Ladiwala
|
|
|
4,402,912
|
|
|
|
131,585
|
|
|
|
338,195
|
|
|
Jenny Alltoft
|
|
|
4,395,928
|
|
|
|
138,569
|
|
|
|
338,195
|
|
|
Mark Capone
|
|
|
4,405,110
|
|
|
|
129,387
|
|
|
|
338,195
|
|
|
Shannon Hall
|
|
|
4,399,078
|
|
|
|
135,419
|
|
|
|
338,195
|
|
|
R. Tony Tripeny
|
|
|
4,352,734
|
|
|
|
181,763
|
|
|
|
338,195
|
|
Proposal 2 -Ratification of the selection by our Audit Committee of Baker Tilly US, LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2027
The appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2027 was approved:
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
|||
|
4,814,383
|
56,778
|
1,531
|
-
|
Proposal 3 -Approval on a non-binding basis of the compensation of the Company's named executive officers
The compensation of the Company's named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis:
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
|||
|
4,317,389
|
136,782
|
80,326
|
338,195
|
Mesa Laboratories Inc. published this content on September 08, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on September 08, 2026 at 19:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]